Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of Warsaw

About this trial

The goal of this clinical trial is to learn if a body-focused mindfulness program can help people with alcohol use disorder (AUD) feel more connected to their bodies and manage their emotions better. The main questions it aims to answer are:

Does the mindfulness program reduce feelings of disconnection from the body (bodily dissociation)? Does it improve awareness of body signals (interoceptive awareness)? Does it lower alcohol craving and reduce the chance of returning to drinking after leaving the hospital? Researchers will compare participants who receive the mindfulness program to participants who receive standard psychoeducation sessions, within the same overall inpatient AUD treatment program.

Participants will:

* Take part in 6 weekly group sessions (90 minutes each) of body-focused mindfulness, which includes breathing exercises, body scan, gentle movement, and group discussion. * Receive audio recordings of guided mindfulness exercises to practice independently between sessions. * Complete questionnaires about their emotions, body awareness, and alcohol craving before and after the program. * Be followed up at 4 weeks, 6 months, and 12 months after leaving the hospital to track their drinking.

Eligibility criteria

Qualifiers

Diagnosis of Alcohol Use Disorder (DSM-5)

Currently admitted to the inpatient AUD treatment program at the study ward

Age 18 years or older

Written informed consent provided

Disqualifiers

Refusal to participate or withdrawal of consent

Severe somatic condition precluding participation in group activities

Current acute psychotic symptoms

Severe affective symptoms requiring intensive intervention

Trial design

Treatments tested in this trial

  • Body-Focused Mindfulness Intervention
  • Standard Psychoeducation

Treatment groups

240 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medical University of Warsaw

Lead sponsor

University of Warsaw

Collaborator